Pacific Biosciences Launches New Sequencing Platform Based on Its SMRT Technology
Sequel™ System Offers Significantly Higher Throughput, Reducing Project Costs and TimelinesMENLO PARK, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced it has launched a new nucleic acid sequencing platform. The Sequel™ System provides higher... Read more